Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05436405 |
Other study ID # |
mansouravascular |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 1, 2018 |
Est. completion date |
April 1, 2020 |
Study information
Verified date |
June 2022 |
Source |
Mansoura University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Background: critical limb ischemia is one of the most challenging cases we face nowadays with
high risk for amputation, retrograde trans-pedal angioplasty offers an alternative technique
after failure of traditional ante-grade angioplasty.
Patients and Methods: 96 patients underwent trans-pedal or trans-tibial retrograde
angioplasty after failure of the traditional ante-grade angioplasty with the aid of US,
21-gauge needle and 0.018 wire through sheath-less approach as a last chance for
revascularization
Description:
Study Design: This prospective non randomized study that had been performed at vascular
surgery department at Mansoura University Hospital between March 2018 and April 2020, who was
selected for 96patients undergoing endovascular BTK revascularization for CLI owing to tibial
vascular diseases and gave written informed consent. Such cases who not give good response
following traditional ante-grade ipsilateral trans-femoral approach and consequently
underwent retrograde Trans-pedal or transtibial access to provide endovascular management for
the lesions.
Inclusion criteria:
- all patients aged from (18-80) years, males and female
- patients with 1ry lesion (without previous trial of angioplasty or bypass)
- 2ry lesion (after previous trial of angioplasty or bypass),
- the patients with fountain classification (stage IIB, stage III, stage IV)
- patients with Rutherford classification (grade I "category 3", grade II, Category 4",
grade III, Category 4&category 5.
Exclusion criteria:
- patients with untreated osteomyelitis,
- patients with mixed lesions with other comorbidities (CVI & Lymphoedema),
- patients with vasculitis or Buerger's dis.
- Also, who can't give consent (mentally retarded patients) or those with behavioral
disorders .
Study tools History Data: included patient's demographics, underlying medical conditions, any
previous surgery, transplanted kidney and other associated morbidity.
Examination: Full arterial assessments included pulse examination, and the ABPI (ankle
brachial pressure index).
Laboratory: Blood picture, Blood sugar level, Kidney functions, Liver functions and
Coagulation profile.
Imaging: Duplex ultra-sonographic (US) examination and CTA. Technique: Entire cases underwent
full therapeutic medication prior to interference. Entire cases were tried ante-grade
re-vascularization with a subsequent failure. A lower limb angiogram was be ready in entire
cases prior to the retrograde procedure performance. Briefly, conventional femoral access
will be conducted in the traditional manner and involve the sheath while the catheter was
introduced close to the proximal degree of lesion.
Access to a pedal vessel: Using a 21-guage needle with insertion of 0.018-inch wire by
sheathless technique (Figure 1) or by utilizing a micro puncture access set. A duplex-guided
access has a great importance in terms of evaluation of the pedal as well as tibial blood
vessels. Such vessel is recognized using the US probe. Color flow is utilized for
identification of the objective artery flow, after that color disappeared while the needle is
utilized for accessing the anterior vascular surface by utilizing duplex US , such approach
performed in 54 patients. There are technical points worth mentioning utilizing such
procedure: usage the smallest ready US as the major ones are bulky and may have a role in
interference with the access process. In addition, marked vascular calcification may induce
marked shadow making the identification very hard to be detected. In such conditions, a
fluoroscopy might enable a good possibility for efficient access. In addition, it was
suggested to utilize micro-puncture needle supposed to have echogenic pattern as the tip of
regular needle is very hard to visualize utilizing the duplex US probe. Also, use of straight
fluoroscopy or road mapping may offer a better chance for successful access, as we mentioned
before, this method is done in 31 cases . Appropriate section of the actual place of vascular
access is essential for the successfulness of such procedure. Generally, a patent vascular is
selected to be the access situation. A micro-puncture needle is utilized for access.
Occasionally, bending the needle tip has the ability to make the possibility of vascular
evaluation easy which has great importance if the access point in the ATA beyond the ankle.
Another method is open method (cut down) on tibial vessels, this method is done in 11 cases.
Following evaluating the artery, established by back hemorrhage, the micro puncture access
wire is introduced via the needle into the vessels underneath fluoroscopic guide in a
retrograde fashion. The needle is removed and micro puncture set (4F) or the balloon itself
is passed over the wire to secure the access. According to micro puncture introducer set it
includes a 21- gauge, 7- cm echogenic needle, 10 - cm long micro puncture 4-french introducer
and 2.9F inner caliber permitting passage of the equipment. When the retrograde introducers
are in position, the case is completely heparinized to prevent any thrombus development
throughout the interference process. An exchange dimension 0.018-inch wire was utilized to
try passing across the disorder in a retrograde manner, it has very accurate outcomes
crossing the obstruction for combination of a small sufficient diameter with adequate body
support to permit crossing of the obstruction calcified in several patients. The V18 TM
Control Wire Guide Wire is specifically beneficial at such condition. It has a hydrophilic
tip which may assist in sliding via the blockade with mild frictions, and simultaneously the
wire has sufficient stiffness to pass across the overall occlusion. In sometimes, the usage
of the 0.018 system only aiming for crossing isn't sufficient. Such condition specifically
develops when there are prolonged occlusions and when there is marked calcification. In such
patients, additional reinforcement is required for the platform to permit the crossing. Thus,
up-sizing to a 0.035 system might help in disorder crossing. When we pass through the
disorder, an angiogram from below is conducted to prove the situation in the actual lumen
beyond the disorder. The 0.018-inch system and wire were removed and hemostasis secured via
digital compression for 8 minutes or by ante-grade balloon dilatation at the site of puncture
for about 2-3 minutes.
Patient follow-up: Patients had been evaluated through the ABPI and duplex US examination:
immediately, three mo., 6 mo., and 1 year following the surgery.